TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-12.46%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.63B
AUM Growth
+$2.63B
(-2.1%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
44.7%
Holding
148
New
38
Increased
32
Reduced
10
Closed
13
Top Buys
| 1 |
UnitedHealth
UNH
|
$36.3M |
| 2 |
Biogen
BIIB
|
$33.3M |
| 3 |
Merck
MRK
|
$24.5M |
| 4 |
United Therapeutics
UTHR
|
$24M |
| 5 |
MDCO
Medicines Co
MDCO
|
$23.7M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$26.5M |
| 2 |
Amgen
AMGN
|
$24.3M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$23.7M |
| 4 |
CELG
Celgene Corp
CELG
|
$23.3M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$22.7M |
Sector Composition
| 1 | Healthcare | 85.75% |
| 2 | Real Estate | 3.66% |
| 3 | Financials | 1.38% |
| 4 | Technology | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$58.6B
| $22.6M | 0.81% |
281,474
+177,979
| +172% | +$14.3M |
|
|
ENDP
27
DELISTED
Endo International plc
ENDP
| $22.2M | 0.8% |
320,321
-5,552
| -2% | -$385K |
|
|
MDRX
28
DELISTED
Veradigm Inc. Common Stock
MDRX
| $22.1M | 0.79% |
1,778,200
| – | – |
|
29
Agilent Technologies
A
$35.5B
| $21.8M | 0.78% |
+635,650
| New | +$21.8M |
|
30
Ventas
VTR
$30.7B
| $20.7M | 0.74% |
369,266
+76,484
| +26% | +$6.33M |
|
31
HCA Healthcare
HCA
$95.4B
| $18.8M | 0.68% |
243,188
+29,400
| +14% | +$2.27M |
|
32
Acadia Pharmaceuticals
ACAD
$4.34B
| $18.6M | 0.67% |
562,500
+192,500
| +52% | +$6.37M |
|
|
DOC
33
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $18.6M | 0.67% |
1,230,772
+179,870
| +17% | +$2.71M |
|
34
iShares Biotechnology ETF
IBB
$5.68B
| $17.5M | 0.63% |
57,670
| – | – |
|
35
Medical Properties Trust
MPW
$2.66B
| $17.3M | 0.62% |
1,564,060
+410,486
| +36% | +$4.54M |
|
36
Novo Nordisk
NVO
$252B
| $16M | 0.57% |
+294,600
| New | +$16M |
|
37
Neurocrine Biosciences
NBIX
$13.5B
| $15M | 0.54% |
375,860
| – | – |
|
38
Omega Healthcare
OHI
$12.5B
| $14.5M | 0.52% |
413,116
| – | – |
|
|
PRTK
39
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $14.5M | 0.52% |
762,581
+71,581
| +10% | +$1.36M |
|
|
ALR
40
DELISTED
Alere Inc
ALR
| $14.3M | 0.52% |
297,901
| – | – |
|
41
Medtronic
MDT
$118B
| $13.9M | 0.5% |
+207,044
| New | +$13.9M |
|
42
McKesson
MCK
$85.9B
| $12.6M | 0.45% |
67,862
| – | – |
|
|
WELL.PRI
43
DELISTED
Welltower Inc.
WELL.PRI
| $12.1M | 0.44% |
200,000
| – | – |
|
|
IPXL
44
DELISTED
Impax Laboratories, Inc.
IPXL
| $12.1M | 0.44% |
344,683
| – | – |
|
45
Stryker
SYK
$149B
| $11.7M | 0.42% |
123,940
| – | – |
|
46
Ardelyx
ARDX
$1.57B
| $11.1M | 0.4% |
+640,270
| New | +$11.1M |
|
47
GSK
GSK
$79.3B
| $11M | 0.39% |
+285,000
| New | +$11M |
|
|
DHC
48
Diversified Healthcare Trust
DHC
$903M
| $10.9M | 0.39% |
670,504
+190,900
| +40% | +$3.09M |
|
49
Sabra Healthcare REIT
SBRA
$4.56B
| $10.6M | 0.38% |
456,190
| – | – |
|
50
Thermo Fisher Scientific
TMO
$183B
| $10.6M | 0.38% |
86,395
| – | – |
|